nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Temozolomide—brain cancer	0.211	0.486	CbGbCtD
Dantrolene—CYP3A4—Lomustine—brain cancer	0.179	0.414	CbGbCtD
Dantrolene—CYP3A4—Etoposide—brain cancer	0.0433	0.1	CbGbCtD
Dantrolene—RYR3—telencephalon—brain cancer	0.0152	0.106	CbGeAlD
Dantrolene—RYR3—pituitary gland—brain cancer	0.0124	0.0859	CbGeAlD
Dantrolene—RYR3—medulla oblongata—brain cancer	0.0119	0.0829	CbGeAlD
Dantrolene—RYR3—midbrain—brain cancer	0.0109	0.0758	CbGeAlD
Dantrolene—RYR3—spinal cord—brain cancer	0.0107	0.0739	CbGeAlD
Dantrolene—RYR3—head—brain cancer	0.00947	0.0657	CbGeAlD
Dantrolene—RYR3—central nervous system—brain cancer	0.00864	0.06	CbGeAlD
Dantrolene—RYR1—medulla oblongata—brain cancer	0.00857	0.0595	CbGeAlD
Dantrolene—RYR3—cerebellum—brain cancer	0.00845	0.0586	CbGeAlD
Dantrolene—RYR1—midbrain—brain cancer	0.00783	0.0544	CbGeAlD
Dantrolene—RYR1—endocrine gland—brain cancer	0.00688	0.0478	CbGeAlD
Dantrolene—RYR3—brain—brain cancer	0.00686	0.0476	CbGeAlD
Dantrolene—RYR1—head—brain cancer	0.00679	0.0471	CbGeAlD
Dantrolene—RYR1—central nervous system—brain cancer	0.0062	0.043	CbGeAlD
Dantrolene—RYR1—cerebellum—brain cancer	0.00606	0.0421	CbGeAlD
Dantrolene—Dysphonia—Procarbazine—brain cancer	0.00549	0.013	CcSEcCtD
Dantrolene—Visual disturbance—Lomustine—brain cancer	0.00545	0.0129	CcSEcCtD
Dantrolene—RYR1—brain—brain cancer	0.00492	0.0342	CbGeAlD
Dantrolene—Nocturia—Procarbazine—brain cancer	0.00487	0.0115	CcSEcCtD
Dantrolene—Hepatotoxicity—Hydroxyurea—brain cancer	0.00453	0.0107	CcSEcCtD
Dantrolene—Renal failure—Lomustine—brain cancer	0.00391	0.00925	CcSEcCtD
Dantrolene—Hepatotoxicity—Carmustine—brain cancer	0.00366	0.00865	CcSEcCtD
Dantrolene—Necrosis—Carmustine—brain cancer	0.0036	0.00851	CcSEcCtD
Dantrolene—Haemoglobin—Lomustine—brain cancer	0.00359	0.00849	CcSEcCtD
Dantrolene—Haemorrhage—Lomustine—brain cancer	0.00357	0.00845	CcSEcCtD
Dantrolene—Hepatotoxicity—Temozolomide—brain cancer	0.00354	0.00836	CcSEcCtD
Dantrolene—Coagulopathy—Temozolomide—brain cancer	0.00351	0.0083	CcSEcCtD
Dantrolene—Visual impairment—Lomustine—brain cancer	0.00344	0.00814	CcSEcCtD
Dantrolene—Speech disorder—Carmustine—brain cancer	0.00329	0.00777	CcSEcCtD
Dantrolene—Diplopia—Procarbazine—brain cancer	0.00328	0.00775	CcSEcCtD
Dantrolene—Extravasation—Carmustine—brain cancer	0.00324	0.00766	CcSEcCtD
Dantrolene—Speech disorder—Temozolomide—brain cancer	0.00318	0.00751	CcSEcCtD
Dantrolene—Pulmonary oedema—Hydroxyurea—brain cancer	0.00311	0.00736	CcSEcCtD
Dantrolene—Dysphagia—Procarbazine—brain cancer	0.00283	0.0067	CcSEcCtD
Dantrolene—Hepatotoxicity—Etoposide—brain cancer	0.00283	0.00669	CcSEcCtD
Dantrolene—Hepatic failure—Hydroxyurea—brain cancer	0.00282	0.00668	CcSEcCtD
Dantrolene—Injection site reaction—Carmustine—brain cancer	0.00281	0.00664	CcSEcCtD
Dantrolene—Eosinophilia—Procarbazine—brain cancer	0.00281	0.00664	CcSEcCtD
Dantrolene—Necrosis—Etoposide—brain cancer	0.00278	0.00658	CcSEcCtD
Dantrolene—Leukopenia—Lomustine—brain cancer	0.00278	0.00658	CcSEcCtD
Dantrolene—Respiratory failure—Temozolomide—brain cancer	0.00278	0.00658	CcSEcCtD
Dantrolene—Urinary incontinence—Carmustine—brain cancer	0.00273	0.00645	CcSEcCtD
Dantrolene—Urinary incontinence—Temozolomide—brain cancer	0.00264	0.00624	CcSEcCtD
Dantrolene—Pollakiuria—Procarbazine—brain cancer	0.00262	0.00619	CcSEcCtD
Dantrolene—Aplastic anaemia—Temozolomide—brain cancer	0.00256	0.00606	CcSEcCtD
Dantrolene—Drowsiness—Procarbazine—brain cancer	0.00253	0.00598	CcSEcCtD
Dantrolene—Extravasation—Etoposide—brain cancer	0.00251	0.00592	CcSEcCtD
Dantrolene—Thrombocytopenia—Lomustine—brain cancer	0.00249	0.00588	CcSEcCtD
Dantrolene—Pain—Carboplatin—brain cancer	0.00248	0.00587	CcSEcCtD
Dantrolene—Sweating—Procarbazine—brain cancer	0.00242	0.00573	CcSEcCtD
Dantrolene—Anorexia—Lomustine—brain cancer	0.00242	0.00572	CcSEcCtD
Dantrolene—Haematuria—Procarbazine—brain cancer	0.00241	0.0057	CcSEcCtD
Dantrolene—Phlebitis—Carmustine—brain cancer	0.00238	0.00563	CcSEcCtD
Dantrolene—Thrombophlebitis—Carmustine—brain cancer	0.00237	0.0056	CcSEcCtD
Dantrolene—Swelling—Carmustine—brain cancer	0.00233	0.0055	CcSEcCtD
Dantrolene—Body temperature increased—Carboplatin—brain cancer	0.00229	0.00542	CcSEcCtD
Dantrolene—Thrombophlebitis—Temozolomide—brain cancer	0.00229	0.00542	CcSEcCtD
Dantrolene—Haemoglobin—Procarbazine—brain cancer	0.00228	0.00539	CcSEcCtD
Dantrolene—Haemorrhage—Procarbazine—brain cancer	0.00227	0.00536	CcSEcCtD
Dantrolene—Decreased appetite—Lomustine—brain cancer	0.00221	0.00522	CcSEcCtD
Dantrolene—Hepatic failure—Temozolomide—brain cancer	0.00221	0.00522	CcSEcCtD
Dantrolene—Flushing—Procarbazine—brain cancer	0.00211	0.00498	CcSEcCtD
Dantrolene—Diplopia—Carmustine—brain cancer	0.00205	0.00485	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00205	0.00485	CcSEcCtD
Dantrolene—Chills—Procarbazine—brain cancer	0.00204	0.00481	CcSEcCtD
Dantrolene—Body temperature increased—Lomustine—brain cancer	0.00201	0.00475	CcSEcCtD
Dantrolene—Diplopia—Temozolomide—brain cancer	0.00198	0.00469	CcSEcCtD
Dantrolene—Drowsiness—Hydroxyurea—brain cancer	0.00196	0.00462	CcSEcCtD
Dantrolene—Tension—Procarbazine—brain cancer	0.00194	0.00458	CcSEcCtD
Dantrolene—Nervousness—Procarbazine—brain cancer	0.00192	0.00454	CcSEcCtD
Dantrolene—Phlebitis—Etoposide—brain cancer	0.00184	0.00435	CcSEcCtD
Dantrolene—Anaemia—Procarbazine—brain cancer	0.00183	0.00432	CcSEcCtD
Dantrolene—Muscular weakness—Carmustine—brain cancer	0.00181	0.00428	CcSEcCtD
Dantrolene—Swelling—Etoposide—brain cancer	0.0018	0.00425	CcSEcCtD
Dantrolene—Dysphagia—Carmustine—brain cancer	0.00177	0.00419	CcSEcCtD
Dantrolene—Leukopenia—Procarbazine—brain cancer	0.00177	0.00418	CcSEcCtD
Dantrolene—Haemoglobin—Hydroxyurea—brain cancer	0.00176	0.00417	CcSEcCtD
Dantrolene—Haemorrhage—Hydroxyurea—brain cancer	0.00176	0.00415	CcSEcCtD
Dantrolene—Muscular weakness—Temozolomide—brain cancer	0.00175	0.00413	CcSEcCtD
Dantrolene—Dysphagia—Temozolomide—brain cancer	0.00171	0.00405	CcSEcCtD
Dantrolene—Convulsion—Procarbazine—brain cancer	0.00171	0.00405	CcSEcCtD
Dantrolene—Hypertension—Procarbazine—brain cancer	0.00171	0.00403	CcSEcCtD
Dantrolene—Myalgia—Procarbazine—brain cancer	0.00168	0.00398	CcSEcCtD
Dantrolene—Dry mouth—Procarbazine—brain cancer	0.00164	0.00389	CcSEcCtD
Dantrolene—Cardiac failure—Etoposide—brain cancer	0.00163	0.00384	CcSEcCtD
Dantrolene—Confusional state—Procarbazine—brain cancer	0.00163	0.00384	CcSEcCtD
Dantrolene—Vomiting—Lomustine—brain cancer	0.00161	0.00382	CcSEcCtD
Dantrolene—Pollakiuria—Temozolomide—brain cancer	0.00158	0.00374	CcSEcCtD
Dantrolene—Thrombocytopenia—Procarbazine—brain cancer	0.00158	0.00373	CcSEcCtD
Dantrolene—Depression—Carmustine—brain cancer	0.00158	0.00373	CcSEcCtD
Dantrolene—Chills—Hydroxyurea—brain cancer	0.00158	0.00373	CcSEcCtD
Dantrolene—Tachycardia—Procarbazine—brain cancer	0.00157	0.00372	CcSEcCtD
Dantrolene—Hyperhidrosis—Procarbazine—brain cancer	0.00156	0.00368	CcSEcCtD
Dantrolene—Renal failure—Carmustine—brain cancer	0.00155	0.00367	CcSEcCtD
Dantrolene—Anorexia—Procarbazine—brain cancer	0.00154	0.00363	CcSEcCtD
Dantrolene—Erythema—Hydroxyurea—brain cancer	0.00153	0.00361	CcSEcCtD
Dantrolene—Depression—Temozolomide—brain cancer	0.00152	0.0036	CcSEcCtD
Dantrolene—Nausea—Lomustine—brain cancer	0.00151	0.00357	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00147	0.00347	CcSEcCtD
Dantrolene—Insomnia—Procarbazine—brain cancer	0.00146	0.00345	CcSEcCtD
Dantrolene—Somnolence—Procarbazine—brain cancer	0.00143	0.00339	CcSEcCtD
Dantrolene—Haemoglobin—Carmustine—brain cancer	0.00143	0.00337	CcSEcCtD
Dantrolene—Haemorrhage—Carmustine—brain cancer	0.00142	0.00336	CcSEcCtD
Dantrolene—Ill-defined disorder—Hydroxyurea—brain cancer	0.00142	0.00335	CcSEcCtD
Dantrolene—Anaemia—Hydroxyurea—brain cancer	0.00141	0.00334	CcSEcCtD
Dantrolene—Decreased appetite—Procarbazine—brain cancer	0.0014	0.00331	CcSEcCtD
Dantrolene—Fatigue—Procarbazine—brain cancer	0.00139	0.00329	CcSEcCtD
Dantrolene—Haemoglobin—Temozolomide—brain cancer	0.00138	0.00326	CcSEcCtD
Dantrolene—Malaise—Hydroxyurea—brain cancer	0.00138	0.00326	CcSEcCtD
Dantrolene—Constipation—Procarbazine—brain cancer	0.00138	0.00326	CcSEcCtD
Dantrolene—Pain—Procarbazine—brain cancer	0.00138	0.00326	CcSEcCtD
Dantrolene—Hepatitis—Temozolomide—brain cancer	0.00137	0.00324	CcSEcCtD
Dantrolene—Haemorrhage—Temozolomide—brain cancer	0.00137	0.00324	CcSEcCtD
Dantrolene—Dysphagia—Etoposide—brain cancer	0.00137	0.00324	CcSEcCtD
Dantrolene—Leukopenia—Hydroxyurea—brain cancer	0.00137	0.00323	CcSEcCtD
Dantrolene—Visual impairment—Carmustine—brain cancer	0.00137	0.00323	CcSEcCtD
Dantrolene—Feeling abnormal—Procarbazine—brain cancer	0.00133	0.00314	CcSEcCtD
Dantrolene—Convulsion—Hydroxyurea—brain cancer	0.00132	0.00313	CcSEcCtD
Dantrolene—Visual impairment—Temozolomide—brain cancer	0.00132	0.00313	CcSEcCtD
Dantrolene—Gastrointestinal pain—Procarbazine—brain cancer	0.00132	0.00312	CcSEcCtD
Dantrolene—Flushing—Carmustine—brain cancer	0.00132	0.00311	CcSEcCtD
Dantrolene—Discomfort—Hydroxyurea—brain cancer	0.00129	0.00304	CcSEcCtD
Dantrolene—Urticaria—Procarbazine—brain cancer	0.00128	0.00303	CcSEcCtD
Dantrolene—Abdominal pain—Procarbazine—brain cancer	0.00127	0.00301	CcSEcCtD
Dantrolene—Body temperature increased—Procarbazine—brain cancer	0.00127	0.00301	CcSEcCtD
Dantrolene—Flushing—Temozolomide—brain cancer	0.00127	0.00301	CcSEcCtD
Dantrolene—Erythema—Carmustine—brain cancer	0.00124	0.00292	CcSEcCtD
Dantrolene—Chills—Temozolomide—brain cancer	0.00123	0.00291	CcSEcCtD
Dantrolene—Thrombocytopenia—Hydroxyurea—brain cancer	0.00122	0.00289	CcSEcCtD
Dantrolene—Renal failure—Etoposide—brain cancer	0.0012	0.00284	CcSEcCtD
Dantrolene—CYP3A4—endocrine gland—brain cancer	0.0012	0.0083	CbGeAlD
Dantrolene—Back pain—Carmustine—brain cancer	0.0012	0.00283	CcSEcCtD
Dantrolene—Erythema—Temozolomide—brain cancer	0.00119	0.00282	CcSEcCtD
Dantrolene—Anorexia—Hydroxyurea—brain cancer	0.00119	0.00281	CcSEcCtD
Dantrolene—Hypersensitivity—Procarbazine—brain cancer	0.00119	0.00281	CcSEcCtD
Dantrolene—Dysgeusia—Temozolomide—brain cancer	0.00117	0.00276	CcSEcCtD
Dantrolene—Vision blurred—Carmustine—brain cancer	0.00116	0.00275	CcSEcCtD
Dantrolene—Asthenia—Procarbazine—brain cancer	0.00116	0.00273	CcSEcCtD
Dantrolene—Back pain—Temozolomide—brain cancer	0.00116	0.00273	CcSEcCtD
Dantrolene—Anaemia—Carmustine—brain cancer	0.00114	0.0027	CcSEcCtD
Dantrolene—Pruritus—Procarbazine—brain cancer	0.00114	0.0027	CcSEcCtD
Dantrolene—Vision blurred—Temozolomide—brain cancer	0.00113	0.00266	CcSEcCtD
Dantrolene—Somnolence—Hydroxyurea—brain cancer	0.00111	0.00262	CcSEcCtD
Dantrolene—Ill-defined disorder—Temozolomide—brain cancer	0.00111	0.00262	CcSEcCtD
Dantrolene—Leukopenia—Carmustine—brain cancer	0.00111	0.00262	CcSEcCtD
Dantrolene—Anaemia—Temozolomide—brain cancer	0.0011	0.00261	CcSEcCtD
Dantrolene—Diarrhoea—Procarbazine—brain cancer	0.0011	0.00261	CcSEcCtD
Dantrolene—Dyspepsia—Hydroxyurea—brain cancer	0.0011	0.0026	CcSEcCtD
Dantrolene—Decreased appetite—Hydroxyurea—brain cancer	0.00108	0.00256	CcSEcCtD
Dantrolene—CYP3A4—central nervous system—brain cancer	0.00108	0.00748	CbGeAlD
Dantrolene—Malaise—Temozolomide—brain cancer	0.00108	0.00255	CcSEcCtD
Dantrolene—Fatigue—Hydroxyurea—brain cancer	0.00108	0.00254	CcSEcCtD
Dantrolene—Convulsion—Carmustine—brain cancer	0.00107	0.00253	CcSEcCtD
Dantrolene—Leukopenia—Temozolomide—brain cancer	0.00107	0.00253	CcSEcCtD
Dantrolene—Hypertension—Carmustine—brain cancer	0.00107	0.00252	CcSEcCtD
Dantrolene—Constipation—Hydroxyurea—brain cancer	0.00107	0.00252	CcSEcCtD
Dantrolene—Pain—Hydroxyurea—brain cancer	0.00107	0.00252	CcSEcCtD
Dantrolene—Dizziness—Procarbazine—brain cancer	0.00107	0.00252	CcSEcCtD
Dantrolene—Myalgia—Carmustine—brain cancer	0.00105	0.00249	CcSEcCtD
Dantrolene—Convulsion—Temozolomide—brain cancer	0.00103	0.00245	CcSEcCtD
Dantrolene—Hypertension—Temozolomide—brain cancer	0.00103	0.00244	CcSEcCtD
Dantrolene—Feeling abnormal—Hydroxyurea—brain cancer	0.00103	0.00243	CcSEcCtD
Dantrolene—Vomiting—Procarbazine—brain cancer	0.00102	0.00242	CcSEcCtD
Dantrolene—Flushing—Etoposide—brain cancer	0.00102	0.00241	CcSEcCtD
Dantrolene—Confusional state—Carmustine—brain cancer	0.00102	0.0024	CcSEcCtD
Dantrolene—Myalgia—Temozolomide—brain cancer	0.00102	0.0024	CcSEcCtD
Dantrolene—Rash—Procarbazine—brain cancer	0.00102	0.0024	CcSEcCtD
Dantrolene—Dermatitis—Procarbazine—brain cancer	0.00102	0.0024	CcSEcCtD
Dantrolene—Headache—Procarbazine—brain cancer	0.00101	0.00239	CcSEcCtD
Dantrolene—Discomfort—Temozolomide—brain cancer	0.001	0.00237	CcSEcCtD
Dantrolene—Dry mouth—Temozolomide—brain cancer	0.000994	0.00235	CcSEcCtD
Dantrolene—Thrombocytopenia—Carmustine—brain cancer	0.000987	0.00233	CcSEcCtD
Dantrolene—Body temperature increased—Hydroxyurea—brain cancer	0.000986	0.00233	CcSEcCtD
Dantrolene—Chills—Etoposide—brain cancer	0.000985	0.00233	CcSEcCtD
Dantrolene—Tachycardia—Carmustine—brain cancer	0.000984	0.00233	CcSEcCtD
Dantrolene—Confusional state—Temozolomide—brain cancer	0.000983	0.00232	CcSEcCtD
Dantrolene—Anaphylactic shock—Temozolomide—brain cancer	0.000975	0.0023	CcSEcCtD
Dantrolene—Anorexia—Carmustine—brain cancer	0.000961	0.00227	CcSEcCtD
Dantrolene—Nausea—Procarbazine—brain cancer	0.000957	0.00226	CcSEcCtD
Dantrolene—Thrombocytopenia—Temozolomide—brain cancer	0.000954	0.00226	CcSEcCtD
Dantrolene—Hyperhidrosis—Temozolomide—brain cancer	0.000942	0.00223	CcSEcCtD
Dantrolene—Dysgeusia—Etoposide—brain cancer	0.000936	0.00221	CcSEcCtD
Dantrolene—Anorexia—Temozolomide—brain cancer	0.000929	0.0022	CcSEcCtD
Dantrolene—Back pain—Etoposide—brain cancer	0.000924	0.00219	CcSEcCtD
Dantrolene—Hypersensitivity—Hydroxyurea—brain cancer	0.000919	0.00217	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Carmustine—brain cancer	0.000919	0.00217	CcSEcCtD
Dantrolene—Insomnia—Carmustine—brain cancer	0.000912	0.00216	CcSEcCtD
Dantrolene—Somnolence—Carmustine—brain cancer	0.000897	0.00212	CcSEcCtD
Dantrolene—Asthenia—Hydroxyurea—brain cancer	0.000895	0.00212	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000888	0.0021	CcSEcCtD
Dantrolene—Ill-defined disorder—Etoposide—brain cancer	0.000887	0.0021	CcSEcCtD
Dantrolene—Anaemia—Etoposide—brain cancer	0.000883	0.00209	CcSEcCtD
Dantrolene—Insomnia—Temozolomide—brain cancer	0.000881	0.00208	CcSEcCtD
Dantrolene—Decreased appetite—Carmustine—brain cancer	0.000877	0.00207	CcSEcCtD
Dantrolene—Somnolence—Temozolomide—brain cancer	0.000866	0.00205	CcSEcCtD
Dantrolene—Pain—Carmustine—brain cancer	0.000862	0.00204	CcSEcCtD
Dantrolene—Constipation—Carmustine—brain cancer	0.000862	0.00204	CcSEcCtD
Dantrolene—Malaise—Etoposide—brain cancer	0.000862	0.00204	CcSEcCtD
Dantrolene—Dyspepsia—Temozolomide—brain cancer	0.000858	0.00203	CcSEcCtD
Dantrolene—Leukopenia—Etoposide—brain cancer	0.000855	0.00202	CcSEcCtD
Dantrolene—Diarrhoea—Hydroxyurea—brain cancer	0.000854	0.00202	CcSEcCtD
Dantrolene—Decreased appetite—Temozolomide—brain cancer	0.000847	0.002	CcSEcCtD
Dantrolene—Fatigue—Temozolomide—brain cancer	0.00084	0.00199	CcSEcCtD
Dantrolene—Pain—Temozolomide—brain cancer	0.000833	0.00197	CcSEcCtD
Dantrolene—Constipation—Temozolomide—brain cancer	0.000833	0.00197	CcSEcCtD
Dantrolene—Feeling abnormal—Carmustine—brain cancer	0.000831	0.00196	CcSEcCtD
Dantrolene—Convulsion—Etoposide—brain cancer	0.000828	0.00196	CcSEcCtD
Dantrolene—Hypertension—Etoposide—brain cancer	0.000825	0.00195	CcSEcCtD
Dantrolene—Dizziness—Hydroxyurea—brain cancer	0.000825	0.00195	CcSEcCtD
Dantrolene—Gastrointestinal pain—Carmustine—brain cancer	0.000825	0.00195	CcSEcCtD
Dantrolene—Discomfort—Etoposide—brain cancer	0.000804	0.0019	CcSEcCtD
Dantrolene—Feeling abnormal—Temozolomide—brain cancer	0.000803	0.0019	CcSEcCtD
Dantrolene—Body temperature increased—Carmustine—brain cancer	0.000797	0.00188	CcSEcCtD
Dantrolene—Abdominal pain—Carmustine—brain cancer	0.000797	0.00188	CcSEcCtD
Dantrolene—Gastrointestinal pain—Temozolomide—brain cancer	0.000797	0.00188	CcSEcCtD
Dantrolene—Vomiting—Hydroxyurea—brain cancer	0.000793	0.00188	CcSEcCtD
Dantrolene—Rash—Hydroxyurea—brain cancer	0.000787	0.00186	CcSEcCtD
Dantrolene—Confusional state—Etoposide—brain cancer	0.000786	0.00186	CcSEcCtD
Dantrolene—Dermatitis—Hydroxyurea—brain cancer	0.000786	0.00186	CcSEcCtD
Dantrolene—Headache—Hydroxyurea—brain cancer	0.000782	0.00185	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—brain cancer	0.00078	0.00184	CcSEcCtD
Dantrolene—Urticaria—Temozolomide—brain cancer	0.000774	0.00183	CcSEcCtD
Dantrolene—Abdominal pain—Temozolomide—brain cancer	0.00077	0.00182	CcSEcCtD
Dantrolene—Body temperature increased—Temozolomide—brain cancer	0.00077	0.00182	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—brain cancer	0.000764	0.00181	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—brain cancer	0.000761	0.0018	CcSEcCtD
Dantrolene—Hyperhidrosis—Etoposide—brain cancer	0.000754	0.00178	CcSEcCtD
Dantrolene—Anorexia—Etoposide—brain cancer	0.000743	0.00176	CcSEcCtD
Dantrolene—Hypersensitivity—Carmustine—brain cancer	0.000743	0.00176	CcSEcCtD
Dantrolene—Nausea—Hydroxyurea—brain cancer	0.000741	0.00175	CcSEcCtD
Dantrolene—Asthenia—Carmustine—brain cancer	0.000724	0.00171	CcSEcCtD
Dantrolene—Hypersensitivity—Temozolomide—brain cancer	0.000718	0.0017	CcSEcCtD
Dantrolene—Asthenia—Temozolomide—brain cancer	0.000699	0.00165	CcSEcCtD
Dantrolene—Somnolence—Etoposide—brain cancer	0.000693	0.00164	CcSEcCtD
Dantrolene—Diarrhoea—Carmustine—brain cancer	0.00069	0.00163	CcSEcCtD
Dantrolene—Pruritus—Temozolomide—brain cancer	0.00069	0.00163	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—brain cancer	0.000678	0.0016	CcSEcCtD
Dantrolene—Fatigue—Etoposide—brain cancer	0.000672	0.00159	CcSEcCtD
Dantrolene—Dizziness—Carmustine—brain cancer	0.000667	0.00158	CcSEcCtD
Dantrolene—Constipation—Etoposide—brain cancer	0.000667	0.00158	CcSEcCtD
Dantrolene—Pain—Etoposide—brain cancer	0.000667	0.00158	CcSEcCtD
Dantrolene—Diarrhoea—Temozolomide—brain cancer	0.000667	0.00158	CcSEcCtD
Dantrolene—Dizziness—Temozolomide—brain cancer	0.000644	0.00152	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—brain cancer	0.000643	0.00152	CcSEcCtD
Dantrolene—Vomiting—Carmustine—brain cancer	0.000641	0.00152	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—brain cancer	0.000638	0.00151	CcSEcCtD
Dantrolene—Rash—Carmustine—brain cancer	0.000636	0.0015	CcSEcCtD
Dantrolene—Dermatitis—Carmustine—brain cancer	0.000635	0.0015	CcSEcCtD
Dantrolene—Headache—Carmustine—brain cancer	0.000632	0.00149	CcSEcCtD
Dantrolene—Vomiting—Temozolomide—brain cancer	0.00062	0.00147	CcSEcCtD
Dantrolene—Urticaria—Etoposide—brain cancer	0.00062	0.00146	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—brain cancer	0.000616	0.00146	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—brain cancer	0.000616	0.00146	CcSEcCtD
Dantrolene—Rash—Temozolomide—brain cancer	0.000614	0.00145	CcSEcCtD
Dantrolene—Dermatitis—Temozolomide—brain cancer	0.000614	0.00145	CcSEcCtD
Dantrolene—Headache—Temozolomide—brain cancer	0.000611	0.00144	CcSEcCtD
Dantrolene—Nausea—Carmustine—brain cancer	0.000599	0.00142	CcSEcCtD
Dantrolene—Nausea—Temozolomide—brain cancer	0.000579	0.00137	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—brain cancer	0.000575	0.00136	CcSEcCtD
Dantrolene—Asthenia—Etoposide—brain cancer	0.00056	0.00132	CcSEcCtD
Dantrolene—Pruritus—Etoposide—brain cancer	0.000552	0.0013	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—brain cancer	0.000534	0.00126	CcSEcCtD
Dantrolene—Dizziness—Etoposide—brain cancer	0.000516	0.00122	CcSEcCtD
Dantrolene—Vomiting—Etoposide—brain cancer	0.000496	0.00117	CcSEcCtD
Dantrolene—Rash—Etoposide—brain cancer	0.000492	0.00116	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—brain cancer	0.000491	0.00116	CcSEcCtD
Dantrolene—Headache—Etoposide—brain cancer	0.000489	0.00116	CcSEcCtD
Dantrolene—Nausea—Etoposide—brain cancer	0.000463	0.0011	CcSEcCtD
